Psicobiología y Metodología en Ciencias del Comportamiento
Departamento
Hospital del Mar
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital del Mar (15)
2022
-
Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
Brain Sciences, Vol. 12, Núm. 5
2020
-
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
Scientific Reports, Vol. 10, Núm. 1
-
Validation of the Neuronorma battery for neuropsychological assessment in multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 42
2019
-
Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
PLoS ONE, Vol. 14, Núm. 3
-
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Neuropharmacology, Vol. 149, pp. 212-220
2018
-
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women
Addiction Biology, Vol. 23, Núm. 6, pp. 1242-1250
-
PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models
Biochemical Pharmacology, Vol. 157, pp. 235-243
2017
-
Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity
Frontiers in Psychiatry, Vol. 7, Núm. JAN
-
Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence
Addiction Biology, Vol. 22, Núm. 5, pp. 1366-1377
2016
-
Can symptoms help in differential diagnosis between substance-induced vs independent psychosis in adults with a lifetime diagnosis of cocaine use disorder?
Psychiatry Research, Vol. 242, pp. 94-100
2015
-
Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity
PLoS ONE, Vol. 10, Núm. 3
-
Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: Influence of cocaine symptom severity and psychiatric co-morbidity
Addiction Biology, Vol. 20, Núm. 4, pp. 756-772
-
Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings
Frontiers in Psychiatry, Vol. 6, Núm. FEB
2014
-
Assessment of the psychotherapeutic effects of ritual ayahuasca use on drug dependency: A pilot study
The Therapeutic Use of Ayahuasca (Springer-Verlag Berlin Heidelberg), pp. 183-196
2013
-
Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: Impact of psychiatric co-morbidity
Addiction Biology, Vol. 18, Núm. 6, pp. 955-969